Suzano S.A.
Suzano S.A. (SUZ) Financial Performance & Income Statement Overview
Analyze Suzano S.A. (SUZ) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Suzano S.A. (SUZ) Income Statement & Financial Overview
Review Suzano S.A. SUZ income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11.55B | $14.18B | $12.27B | $11.49B |
| Cost of Revenue | $7.73B | $8.76B | $6.85B | $6.09B |
| Gross Profit | $3.82B | $5.42B | $5.43B | $5.40B |
| Gross Profit Ratio | $0.33 | $0.38 | $0.44 | $0.47 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.43B | $1.85B | $1.30B | $1.26B |
| Operating Expenses | $1.56B | $1.000B | $1.32B | $787.25M |
| Total Costs & Expenses | $9.29B | $9.76B | $8.16B | $6.88B |
| Interest Income | $348.43M | $385.71M | $420.94M | $456.89M |
| Interest Expense | $1.64B | $1.69B | $1.57B | $1.15B |
| Depreciation & Amortization | $2.41B | $2.72B | $2.30B | $2.13B |
| EBITDA | $4.84B | -$6.64B | $8.86B | -$3.19B |
| EBITDA Ratio | $0.42 | -$0.47 | $0.72 | -$0.28 |
| Operating Income | $2.26B | $4.42B | $4.11B | $4.61B |
| Operating Income Ratio | $0.20 | $0.31 | $0.33 | $0.40 |
| Other Income/Expenses (Net) | $7.70B | -$15.56B | $867.76M | -$11.07B |
| Income Before Tax | $9.96B | -$11.14B | $4.98B | -$6.46B |
| Income Before Tax Ratio | $0.86 | -$0.79 | $0.41 | -$0.56 |
| Income Tax Expense | $3.61B | -$4.40B | $1.74B | -$2.69B |
| Net Income | $6.34B | -$6.74B | $3.22B | -$3.77B |
| Net Income Ratio | $0.55 | -$0.48 | $0.26 | -$0.33 |
| EPS | $5.12 | -$5.44 | $2.58 | -$2.94 |
| Diluted EPS | $5.10 | -$5.44 | $2.57 | -$2.94 |
| Weighted Avg Shares Outstanding | $1.24B | $1.24B | $1.25B | $1.28B |
| Weighted Avg Shares Outstanding (Diluted) | $1.24B | $1.24B | $1.25B | $1.28B |
Over the last four quarters, Suzano S.A. achieved steady financial progress, growing revenue from $11.49B in Q2 2024 to $11.55B in Q1 2025. Gross profit stayed firm with margins at 33% in Q1 2025 versus 47% in Q2 2024. Operating income totaled $2.26B in Q1 2025, maintaining a 20% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $4.84B. Net income rose to $6.34B, with EPS at $5.12. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan